SCHEMBL8253274

SCHEMBL8253274

C=S(=O)(Cl)c1cccc(F)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
NFE2L2 Q16236 10/20 0.42
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
PGR P06401 1/20 0.41
KAT6A Q92794 2/20 0.40
GBA1 P04062 1/20 0.40
PKM P14618 1/20 0.39
PKLR P30613 1/20 0.39
HTR2A P28223 1/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL67448 0.83 ALDH1A1 (0.52) CA12CA1CA2CA9NFE2L2
SCHEMBL775608 0.78 HTR2C (0.59) CA12CA1CA2CA9NFE2L2
SCHEMBL851628 0.77 CES2 (0.46) CA12CA1CA2CA9NFE2L2
SCHEMBL7534260 0.76 HTR2A (0.50) CA12CA1CA2CA9NFE2L2
SCHEMBL15514618 0.76 CA12 (0.47) CA12CA1CA2CA9NFE2L2
SCHEMBL1889098 0.76 CA12 (0.47) CA12CA1CA2CA9NFE2L2
SCHEMBL2045020 0.74 TSHR (0.57) CA12CA1CA2CA9NFE2L2
SCHEMBL775429 0.74 PTGS2 (0.47) CA12CA1CA2CA9NFE2L2
SCHEMBL1137782 0.74 CA2 (0.70) CA12CA1CA2CA9
SCHEMBL1299098 0.74 CA12 (0.46) CA12CA1CA2CA9NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006116157-A9 DIPEPTIDYL PEPTIDASE-IV INHIBITORS ALANTOS PHARMACEUTICALS INC (US) 2007-03-01 WO disclosed
WO-2006116157-A2 DIPEPTIDYL PEPTIDASE-IV INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2006-11-02 WO disclosed